Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' JETT JR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jett, JR
      Spiral computed tomography screening fur lung cancer is ready for prime time

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    2. Thomas, CF; Tazelaar, HD; Jett, JR
      Typical and atypical pulmonary carcinoids - outcome in patients presentingwith regional lymph node involvement

      CHEST
    3. Nicholson, SA; Okby, NT; Khan, MA; Welsh, JA; McMenamin, MG; Travis, WD; Jett, JR; Tazelaar, HD; Trastek, V; Pairolero, PC; Corn, PG; Herman, JG; Liotta, LA; Caporaso, NE; Harris, CC
      Alterations of p14(ARF), p53, and p73 genes involved in the E2F-1-mediatedapoptotic pathways in non-small cell lung carcinoma

      CANCER RESEARCH
    4. Jett, JR
      Screening for lung cancer in high-risk groups: Current status of low-dose spiral CT scanning and sputum markers

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    5. Weitz, JJ; Marschke, RF; Sloan, JA; Grill, JP; Jett, JR; Knost, JA; Hatfield, AK; Zenk, DW; Bate, WW; Schaefer, PL
      A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer

      LUNG CANCER
    6. Bonner, JA; Sloan, JA; Shanahan, TG; Brooks, BJ; Marks, RS; Krook, JE; Gerstner, JB; Maksymiuk, A; Levitt, R; Mailliard, JA; Tazelaar, HD; Hillman, S; Jett, JR
      Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    7. Kirschling, RJ; Grill, JP; Marks, RS; Kugler, JW; Gerstner, JB; Kuross, SA; Michalak, JC; Windschitl, HE; Krewer, KD; Jett, JR
      Paclitaxel and G-CSF in previously untreated patients with extensive stagesmall-cell lung cancer - A phase II study of the North Central Cancer Treatment Group

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    8. Marschke, RF; Grill, JP; Sloan, JA; Wender, DB; Levitt, R; Mailliard, JA; Gerstner, JB; Ghosh, C; Morton, RF; Jett, JR
      Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    9. Egan, AJM; Boardman, LA; Tazelaar, HD; Swensen, SJ; Jett, JR; Yousem, SA; Myers, JL
      Erdheim-Chester disease - Clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    10. Jett, JR
      Is there a role for adjuvant therapy for resected non-small cell lung cancer?

      THORAX
    11. BENNETT WP; ELDEIRY WS; RUSH WL; GUINEE DG; FREEDMAN AN; CAPORASO NE; WELSH JA; JONES RT; BORKOWSKI A; TRAVIS WD; FLEMING MV; TRASTEK V; PAIROLERO PC; TAZELAAR HD; MIDTHUN D; JETT JR; LIOTTA LA; HARRIS CC
      P21(WAF1 CIP1) AND TRANSFORMING-GROWTH-FACTOR BETA-1 PROTEIN EXPRESSION CORRELATE WITH SURVIVAL IN NONSMALL CELL LUNG-CANCER/

      Clinical cancer research
    12. Przygodzki, RM; Bennett, WP; Guinee, DG; Khan, MA; Freedman, A; Shields, PG; Travis, WD; Jett, JR; Tazelaar, H; Pairolero, P; Trastek, V; Liotta, LA; Harris, CC; Caporaso, NE
      p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer

      PHARMACOGENETICS
    13. EGAN AJM; BOARDMAN LA; MYERS JL; TAZELAAR HD; ODUFFY JD; SWENSEN SJ; JETT JR
      ERDHEIM-CHESTER-DISEASE CAUSING INTERSTITIAL LUNG-DISEASE

      Modern pathology
    14. JUNG SH; LLOYD RV; RUSH WR; PRZYGODZKI R; CAPORASO N; FLEMING MV; BENNETT W; PAIROLERO P; TRASTEK V; JETT JR; LIOTTA LA; HARRIS CC; TAZELAAR HD; TRAVIS WD
      IN-SITU HYBRIDIZATION (ISH) FOR TRANSFORMING-GROWTH-FACTOR (TGF)-BETA-1, (TGF)-BETA-3, AND TGF-RECEPTOR-II (RII) MESSENGER-RNA IN NONSMALL CELL LUNG-CARCINOMA (NSCLC)

      Modern pathology
    15. Maksymiuk, AW; Marschke, RF; Tazelaar, HD; Grill, J; Nair, S; Marks, RS; Brooks, BJ; Mailliard, JA; Burton, GM; Jett, JR
      Phase II trial of topotecan for the treatment of mesothelioma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    16. ARCASOY SM; JETT JR
      PANCOASTS-SYNDROME - REPLY

      The New England journal of medicine
    17. GHAEMMAGHAMI M; JETT JR
      NEW AGENTS IN THE TREATMENT OF SMALL-CELL LUNG-CANCER

      Chest
    18. JETT JR
      UNCOMMON THORACIC TUMORS OF THE LUNG AND MEDIASTINUM - PREFACE

      Seminars in respiratory and critical care medicine
    19. LUKETICH JD; JETT JR
      THE CURRENT MANAGEMENT OF THYMIC TUMORS

      Seminars in respiratory and critical care medicine
    20. ARCASOY SM; BAJWA MK; JETT JR
      NON-HODGKINS-LYMPHOMA PRESENTING AS PANCOASTS-SYNDROME

      Respiratory medicine
    21. MIDTHUN DE; JETT JR
      CHEMOTHERAPY FOR ADVANCED LUNG-CANCER - WHEN TO EXPECT A RESPONSE

      Postgraduate medicine
    22. ARCASOY SM; JETT JR
      SUPERIOR PULMONARY SULCUS TUMORS AND PANOASTS-SYNDROME

      The New England journal of medicine
    23. STROLLO DC; ROSADODECHRISTENSON CML; JETT JR
      PRIMARY MEDIASTINAL TUMORS .2. TUMORS OF THE MIDDLE AND POSTERIOR MEDIASTINUM

      Chest
    24. STROLLO DC; DECHRISTENSON MLR; JETT JR
      PRIMARY MEDIASTINAL TUMORS .1. TUMORS OF THE ANTERIOR MEDIASTINUM

      Chest
    25. JETT JR
      WHATS NEW IN STAGING OF LUNG-CANCER

      Chest
    26. TRIVERS GE; DEBENEDETTI VMG; CAWLEY HL; CARON G; HARRINGTON AM; BENNETT WP; JETT JR; COLBY TV; TAZELAAR H; PAIROLERO P; MILLER RD; HARRIS CC
      ANTI-P53 ANTIBODIES IN SERA FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE CAN PREDATE A DIAGNOSIS OF CANCER

      Clinical cancer research
    27. ROWLAND KM; LOPRINZI CL; SHAW EG; MAKSYMIUK AW; KUROSS SA; JUNG SH; KUGLER JW; TSCHETTER LK; GHOSH C; SCHAEFER PL; OWEN D; WASHBURN JH; WEBB TA; MAILLIARD JA; JETT JR
      RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF CISPLATIN AND ETOPOSIDE PLUS MEGESTROL-ACETATE PLACEBO IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY

      Journal of clinical oncology
    28. SHAW EG; FRYTAK S; EAGAN RT; RICHARDSON RL; CREAGAN ET; JETT JR; FOOTE RL; SU JQ; SCHAID DJ; LEE RE
      ETOPOSIDE-CISPLATIN AND THORACIC RADIATION-THERAPY SALVAGE OF INCOMPLETE RESPONDERS TO A NONCISPLATIN INDUCTION REGIMEN FOR LIMITED AND EXTENSIVE SMALL-CELL CARCINOMA OF THE LUNG

      American journal of clinical oncology
    29. FRYTAK S; SHAW EG; JETT JR; RICHARDSON RL; FOOTE RL; CREAGAN ET; EAGAN RT; SU JQ
      INFUSION CISPLATIN CHEMOTHERAPY AND HYPERFRACTIONATED THORACIC RADIOTHERAPY FOR SMALL-CELL LUNG-CANCER

      American journal of clinical oncology
    30. BENNETT WP; ELDEIRY WS; GUINEE DG; CAPORASO NE; WELSH JA; JONES RT; BORKOWSKI A; TRAVIS WD; COLBY TV; TRASTEK V; PAIROLERO PC; TAZELAAR HF; MIDTHUN D; JETT JR; LIOTTA LA; VOGELSTEIN B; HARRIS CC
      P53 P21((WAF1/CIP1)) EXPRESSION IN HUMAN LUNG-CANCER/

      Laboratory investigation
    31. CASTRO M; VEEDER MH; MAILLIARD JA; TAZELAAR HD; JETT JR
      A PROSPECTIVE-STUDY OF PULMONARY-FUNCTION IN PATIENTS RECEIVING MITOMYCIN

      Chest
    32. HRUSZKEWYCZ AM; DELGADO RM; PRZYGODZKI RM; TRAVIS WD; JETT JR; COLBY TV; LIOTTA LA; KHAN MA; HARRIS CC; BENNETT WP
      RAPID BASE SEQUENCE-ANALYSIS OF MUTANT HUMAN K-RAS ONCOGENE USING SEMIAUTOMATED COLD SSCP

      Clinical chemistry
    33. ALBERTI W; ANDERSON G; BARTOLUCCI A; BELL D; VILLALBA JB; BRODIN O; CARDIELLO C; CARTEI F; CARTEI G; CELLERINO R; CHASTANG C; CORMIER Y; COX JD; CRINO L; CROWLEY J; DAUTZENBERG B; DEPIERRE A; DIETEMANN A; DILLMAN RO; DOI O; FELD R; FIGLIN R; GANZ PA; GREEN MR; GREGOR A; HELLE PA; HERNDON JE; HITOMI S; HOST H; IMAIZUMI M; JETT JR; JOHNSON D; KAASA S; KIMURA H; KLASTERSKY J; KONDO H; KREISMAN H; KRIS MG; KUNISHIMA K; KUWAHARA O; LAD TE; LAING AH; MACBETH F; MASAOKA A; MATTSON K; MINATEL E; MIRA JG; MORI T; MOUNTAIN CF; NIEDERLE N; NIIRANEN A; NOU E; PAGE W; PATER J; PIANTADOSI S; PISTERS KMW; PYRHONEN S; QUOIX E; RAPP E; ROWELL NP; SAHMOUD T; SAWAMURA K; SCHALLIER DCC; SCOTT C; SIMPSON J; STAGG M; TERAMATSU T; TROVO MG; TSUCHIYA R; TUMMARELLO D; VANHOUTTE P; VANZANDWIJK N; VINCENT RG; WADA H; WHITE JE; WILLIAMS CJ; WOODS RL; YAMAGUCHI Y; ARRIAGADA R; CARTMELLDAVIES J; GIRLING DJ; LECHEVALIER T; MARSONI S; PARMAR MKB; PIGNON JP; REKACEWICZ C; SOUHAMI RL; STEWART LA; TARAYRE M; TINAZZI A; TONI V
      CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS

      BMJ. British medical journal
    34. JETT JR; KIRSCHLING RJ; JUNG SH; MARKS RS
      A PHASE-II STUDY OF PACLITAXEL AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PREVIOUSLY UNTREATED PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER - A STUDY OF THE NORTH CENTRAL CANCER-TREATMENT GROUP

      Seminars in oncology
    35. JETT JR
      MALIGNANT PLEURAL MESOTHELIOMA - A PROPOSED NEW STAGING SYSTEM

      Chest
    36. LOPRINZI CL; GOLDBERG RM; SU JQ; MAILLIARD JA; KUROSS SA; MAKSYMIUK AW; KUGLER JW; JETT JR; GHOSH C; PFEIFLE DM; WENDER DB; BURCH PA
      PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    37. LIENGSWANGWONG V; BONNER JA; SHAW EG; FOOTE RL; FRYTAK S; EAGAN RT; JETT JR; RICHARDSON RL; CREAGAN ET; SU JQ
      LIMITED-STAGE SMALL-CELL LUNG-CANCER - PATTERNS OF INTRATHORACIC RECURRENCE AND THE IMPLICATIONS FOR THORACIC RADIOTHERAPY

      Journal of clinical oncology
    38. JETT JR; SU JQ; KROOK JE; GOLDBERG RM; KUGLER JW
      MEASURABLE OR ASSESSABLE DISEASE IN LUNG-CANCER TRIALS - DOES IT MATTER

      Journal of clinical oncology
    39. JETT JR; MAKSYMIUK AW; SU JQ; MAILLIARD JA; KROOK JE; TSCHETTER LK; KARDINAL CG; TWITO DI; LEVITT R; GERSTNER JB
      PHASE-III TRIAL OF RECOMBINANT INTERFERON-GAMMA IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    40. SHAW EG; SU JQ; EAGAN RT; JETT JR; MAKSYMIUK AW; DEIGERT FA
      PROPHYLACTIC CRANIAL IRRADIATION IN COMPLETE RESPONDERS WITH SMALL-CELL LUNG-CANCER - ANALYSIS OF THE MAYO-CLINIC AND NORTH-CENTRAL-CANCER-TREATMENT-GROUP DATA-BASES

      Journal of clinical oncology
    41. MAKSYMIUK AW; JETT JR; EARLE JD; SU JQ; DIEGERT FA; MAILLIARD JA; KARDINAL CG; KROOK JE; VEEDER MH; WIESENFELD M; TSCHETTER LK; LEVITT R
      SEQUENCING AND SCHEDULE EFFECTS OF CISPLATIN PLUS ETOPOSIDE IN SMALL-CELL LUNG-CANCER - RESULTS OF A NORTH CENTRAL CANCER-TREATMENT GROUP RANDOMIZED CLINICAL-TRIAL

      Journal of clinical oncology
    42. WIESENFELD A; JETT JR; SU JQ; BRAICH TA; KARDINAL CG; MAILLIARD JA; VEEDER MH; MORTON RF; MICHALAK JC
      PHASE-II TRIAL OF EDATREXATE IN SMALL-CELL LUNG-CANCER

      Cancer
    43. JETT JR
      CURRENT TREATMENT OF UNRESECTABLE LUNG-CANCER

      Mayo Clinic proceedings
    44. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
      A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP

      Cancer
    45. PUJOL JL; GIBNEY DJ; SU JQ; MAKSYMIUK AW; JETT JR
      IMMUNE-RESPONSE INDUCED IN SMALL-CELL LUNG-CANCER BY MAINTENANCE THERAPY WITH INTERFERON-GAMMA

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 15:04:59